Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance

3 Dec 2022

Abstract excerpt

Colorectal cancer is a serious threat to human health. Poor prognosis and frequently reported drug resistance urges research into novel biomarkers and mechanisms to aid in the understanding of the development and progression of colorectal cancer and to optimise therapeutic strategies. In the current study, we investigated the roles of a putative tumour suppressor, EPLIN, in colorectal cancer. Our clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Synthase and ATPases Research
Share to Cancer Cells and Metastasis
Share to Heat shock proteins research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36499558
DOI: 10.3390/ijms232315232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug ResistancePMID 36499558Read ↗

ELAPOR1 suppresses tumor progression in colorectal cancer and indicates favorable prognosisSemantic proximity Read ↗

EPLIN: a fundamental actin regulator in cancer metastasis?Semantic proximity Read ↗

CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signalingSemantic proximity Read ↗

Comprehensive Analysis of Potential Prognostic Values of ANGPTLs in Colorectal CancerSemantic proximity Read ↗

DPEP1 Increases Drug Resistance in an ASCL2-Dependent Manner in Colon Cancer Cells and Correlates with Immune Cell InfiltrationSemantic proximity Read ↗

Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressorSemantic proximity Read ↗

Revisiting the Roles of Pro-Metastatic EpCAM in CancerSemantic proximity Read ↗

OLFM4, KNG1 and Sec24C identified by proteomics and immunohistochemistry as potential markers of early colorectal cancer stagesSemantic proximity Read ↗

Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin familySemantic proximity Read ↗

Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal CancerSemantic proximity Read ↗

Cyclophilin B induces chemoresistance by degrading wild‐type p53 via interaction with MDM2 in colorectal cancerSemantic proximity Read ↗

Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedsideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.